GSK217
Product Specifications
UNSPSC Description
GSK217
is a potent, selective, and highly soluble bromo and extraterminal domain (BET)
second bromodomain (BD2) inhibitor. GSK217 can be used for
the research of oncology and immune inflammation research[1].
Target Antigen
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/gsk217.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC(C2=CN(C)N=N2)=NC(CC3=C4C=CNC4=CC=C3)=C1)NCC
Molecular Weight
360.41
References & Citations
[1]Aylott HE, et al. Template-Hopping Approach Leads to Potent, Selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) Inhibitors. J Med Chem. 2021 Mar 25;64(6):3249-3281.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-153242/GSK217-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-153242/
Clinical Information
No Development Reported
CAS Number
2748687-92-3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
EH6667 96 Tests
Human BCL2L14 (Apoptosis facilitator Bcl-2-like protein 14) ELISA Kit
Ask
View Details 
AP71143-01 20 µg
Recombinant Escherichia coli Lipopolysaccharide export system protein lptA(lptA)
Ask
View Details AP71143-02 100 µg
Recombinant Escherichia coli Lipopolysaccharide export system protein lptA(lptA)
Ask
View Details